Cerebral Palsy Alliance Report issue

Foundation Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2016
NCT03087110
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Cerebral Palsy Alliance | Cerebral Palsy Alliance Research Institute